Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection
PHASE1CompletedINTERVENTIONAL
Enrollment
31
Participants
Timeline
Start Date
June 30, 1994
Study Completion Date
January 31, 2002
Conditions
Acquired Immunodeficiency SyndromeHIV Infection
Interventions
DRUG
PCLUS 3-18 MN
DRUG
PCLUS 6.1 MN
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001386 - Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection | Biotech Hunter | Biotech Hunter